Statistics
Publications
7
Citations
245
H-Index
7
Active since
2018
Lanlin Shen is an author at Second Affiliated Hospital of Dalian Medical University specializing in oncology, medicine, and molecular oncology.
Publications per year
2018–2024
7
7
MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer
Jingyan Yi, Chongya Liu, Zhiwei Tao et al. · EBioMedicine · 2019 · 112 citations · Full text
Medicine, Oncology, Pharmacology +17
Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer
Min Wang, Yijue Xue, Lanlin Shen et al. · Redox Biology · 2019 · 36 citations · Full text
1–5 of 7